Pepaxto

FDA Rescinds Approval of Oncopeptides' Blood Cancer Treatment: Implications and What's Next
Medriva
Mon, 02/26/24 - 10:44 am
Oncopeptides
Pepaxto
FDA
Multiple Myeloma
FDA looks to pull approval for Oncopeptides' troubled multiple myeloma drug Pepaxto
Fierce Pharma
Thu, 12/8/22 - 10:01 am
Oncopeptides
Multiple Myeloma
Pepaxto
FDA
Oncopeptides Sees Redemption with Positive Multiple Myeloma Data after ODAC Vote
BioSpace
Wed, 10/26/22 - 06:40 pm
Oncopeptides
clinical trials
Pepaxto
relapsed or refractory multiple myeloma
FDA advisory committee issues back to back negative votes on two cancer drugs
MedCity News
Mon, 09/26/22 - 10:31 am
FDA
Spectrum Pharmaceuticals
Oncopeptides
clinical trials
poziotinib
Pepaxto
Multiple Myeloma
Despite being approved in Europe, Oncopeptides' Pepaxto will remain sidelined in the US
Fierce Pharma
Sun, 09/25/22 - 02:00 pm
FDA
Oncopeptides
Multiple Myeloma
Pepaxto
FDA slams Spectrum and Oncopeptides cancer drugs over efficacy concerns ahead of ODAC meeting
Endpoints
Tue, 09/20/22 - 08:40 pm
FDA
oncology
Spectrum Pharmaceuticals
Oncopeptides
poziotinib
Pepaxto
Months after pulling only drug from US, Oncopeptides takes back withdrawal request — but stays mum on why
Endpoints
Mon, 01/24/22 - 10:16 am
Oncopeptides
FDA
Pepaxto
Multiple Myeloma
Oncopeptides' shares crash as it pulls Pepaxto from the market, plans to shut down commercial units
Fierce Pharma
Sun, 10/24/21 - 10:28 pm
Oncopeptides
Pepaxto